Modular Tissue Scaffolds with Dovetail Connectors
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current degradable tissue scaffolds for bone and cartilage defects are often custom-designed and expensive, making them impractical for variable-sized defects, and existing modular implants are typically made from permanent materials that cause stress shielding and inflammatory responses due to material mismatch with bone.
Innovation Solution
A modular tissue scaffold system comprising biocompatible, degradable modules with dovetail connectors and a porous microstructure, synthesized from polycaprolactone and coated with calcium-deficient carbonate-containing hydroxyapatite, allowing for adjustable fitting and integration with a scaffold rack to fill tissue gaps, reducing stress shielding and inflammatory responses.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If custom-designed scaffolds are used to fit variable-sized defects, then the scaffold can precisely fill the tissue gap, but the cost and preparation time increase significantly
Solution Approach 1:
The scaffold is divided into multiple standardized modules that can be assembled in different quantities to match various defect sizes. Each module has standardized connectors (A connector and B connector) that enable easy assembly without custom design, thus maintaining manufacturing precision while reducing device complexity.
Solution Approach 2:
The standardized modules are designed to be universally applicable across different defect sizes and locations. The same module design with standardized connectors can be used for various tissue gaps by simply varying the number of modules assembled, eliminating the need for custom design for each case.
2Strength
If permanent materials are used in modular implants, then the structural strength is sufficient, but stress shielding and inflammatory responses occur due to material mismatch with bone
Solution Approach 1:
The material properties are changed from permanent to degradable, allowing the scaffold to gradually lose mechanical strength as bone regenerates. This parameter change eliminates stress shielding by transferring load to the regenerating bone and avoids inflammatory responses associated with permanent foreign materials.
Solution Approach 2:
The scaffold uses composite materials combining degradable polymers with bone-conductive ceramics or growth factors. This composite approach maintains sufficient structural strength during the early healing phase while the degradable component prevents long-term stress shielding and the bioactive component promotes bone integration without inflammation.
3Object-affected harmful factors
If degradable materials are used in the scaffold, then stress shielding and inflammatory responses are reduced, but the mechanical strength may be insufficient compared to permanent materials
Solution Approach 1:
The scaffold combines degradable polymer matrices with reinforcing elements such as nanofibers, hydroxyapatite particles, or tricalcium phosphate. This composite structure provides sufficient mechanical strength to support the tissue during healing while maintaining the benefits of degradable materials including reduced stress shielding and improved biocompatibility.
Solution Approach 2:
Different regions of the scaffold have different material compositions optimized for their specific functions. Load-bearing regions contain higher concentrations of reinforcing materials for maximum strength, while other regions prioritize degradability and bone conductivity. This local quality variation allows the scaffold to achieve both high strength and reduced harmful effects.
Data Source
AI summary
Provided are biocompatible and implantable scaffolds for treating a tissue defect, such as a bone gap. The scaffolds can have a modular design comprising a tissue scaffold rack designed to accommodate one or more modules. Also provided are methods for fabrication and use of such scaffolds.